Drink water consistently throughout the day rather than consuming large amounts with meals, which can contribute to uncomfortable fullness
49.50 Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide of significant interest in metabolic research
In TRIUMPH-4, 20.9% of participants on the 12mg dose reported dysesthesia , compared to just 0.7% on placebo
Slight yellowing over several weeks is normal
The goal here is to prevent boredom with your meals, which makes sticking to your plan more doable and fun
Retrieved from Gimunov, M., Bozdch, M., Novk, J., et al